Literature DB >> 2948820

In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.

D Guay, R Klicker, T Pence, P Peterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2948820     DOI： 10.1007/bf02013294

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.

Authors:  J S Wolfson; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

2.  Activity of teicoplanin against coagulase-negative staphylococci isolated from patients undergoing continuous peritoneal dialysis.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

3.  Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins.

Authors:  D H Appleby; J F John
Journal:  Nephron       Date:  1982       Impact factor: 2.847

4.  Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.

Authors:  H A Verbrugh; W F Keane; W E Conroy; P K Peterson
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

5.  In vitro activity of teichomycin compared with those of other antibiotics.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

6.  In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid.

Authors:  I Shalit; D F Welch; V H San Joaquin; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191
  6 in total
  6 in total

1.  Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.

Authors:  D R Guay; W M Awni; C E Halstenson; M T Kenny; W F Keane; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

2.  Influence of carbon dioxide on growth and antibiotic susceptibility of coagulase-negative staphylococci cultured in human peritoneal dialysate.

Authors:  M H Wilcox; D G Smith; J A Evans; S P Denyer; R G Finch; P Williams
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

Review 3.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

4.  In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.

Authors:  D C Halstead; J Guzzo; J A Giardina; A E Geshan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 5.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

6.  Susceptibility testing of bacteria recovered from patients with peritonitis complicating continuous ambulatory peritoneal dialysis.

Authors:  H Ludlam; L Johnston; P Hopkins
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.